Rep. Daniel S. Goldman sold Viatris (VTRS)
Rep. Daniel S. Goldman (D-NY-10) · $1K–$15K · traded Apr 10, 2023
- Transaction
- Sold (partial)
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Apr 10, 2023
- Disclosed
- May 19, 2023
- Days to disclose
- 39
- Asset type
- Stock
- As filed
- Viatris Inc.
- Industry
- Drug Manufacturers - Specialty & Generic · Healthcare
Other trades in this filing
All of Goldman's trades →- May 19, 2023$250K–$500K
Bought N Y ST ENV FACS CORP REV 5% 05/15/26 MN
$250K–$500K · Traded Apr 26, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Sold SOUTH ORANGE VLG TWP N J GO 4% 01/15/27
$250K–$500K · Traded Apr 25, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Sold HOOVER ALA GO 4% 07/01/36 JJ
$250K–$500K · Traded Apr 25, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Sold EWING TWP N J GO 4% 11/15/25 MN
$250K–$500K · Traded Apr 25, 2023 · disclosed May 19, 2023
- May 19, 2023$100K–$250K
Bought SCHENECTADY N Y GO 4% 05/01/26 MN
$100K–$250K · Traded Apr 20, 2023 · disclosed May 19, 2023
- May 19, 2023$100K–$250K
Sold NEW JERSEY (STATE OF) GO 5% 06/01/28 JD
$100K–$250K · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Bought N Y CITY MUN WTR FIN AUTH REV 5.0000% 06/15/31 JD
$250K–$500K · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Bought COLONIE N Y GO 4% 03/08/24 MS
$250K–$500K · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$500K–$1M
Sold N J ENV INFRASTRUCTURE TR REV 4% 09/01/27-CA MS
$500K–$1M · Traded Apr 19, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought TELSTRA GROUP LTD SPONSORED ADR CMN (TLGPY)
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought SOFTBANK CORP. ADR CMN (SOBKY)
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$250K–$500K
Bought DORM AUTH OF THE STATE OF NY REV 5.0000% 10/01/26 AO
$250K–$500K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$15K–$50K
$15K–$50K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$50K–$100K
$50K–$100K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought Computershare Limited CMSQY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought Qantas Airways Limited QABSY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Sold (partial) MIAMI-DADE CNTY FLA 5% 07-01- 2025 BEO
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought West Japan Railway Company WJRYY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Bought Central Japan Railway Company CJPRY
$1K–$15K · Traded Apr 13, 2023 · disclosed May 19, 2023
- May 19, 2023$100K–$250K
Bought LOCKPORT CITY N Y SCH DIST GO 5% 04/15/28 AO
$100K–$250K · Traded Apr 12, 2023 · disclosed May 19, 2023
Recent Congress trades in VTRS
- Dec 15, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Nov 18, 2025 · disclosed Dec 15, 2025
- May 8, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Apr 8, 2025 · disclosed May 8, 2025
- Apr 7, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Mar 31, 2025 · disclosed Apr 7, 2025
- Mar 27, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Feb 25, 2025 · disclosed Mar 27, 2025
- Dec 5, 2024$1K–$15K
- Apr 17, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- Feb 24, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Sep 15, 2022$1K–$15K
Sen. Tommy Tuberville (R-AL)
$1K–$15K · Traded Aug 1, 2022 · disclosed Sep 15, 2022
Company context for VTRS
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
VTRS: third_quarter 2026 lobbying report
S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S. 2658, The Medication Affordability and Patent Integrity Act IP Issues related to generic medicines Patent Settlements Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act Policy related to corporate
Public: Oct 20, 2026, 8:43 PM EDTOriginal source ↗VTRS: third_quarter 2026 lobbying report
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071). Trade issues related to generic medicines.
Public: Oct 19, 2026, 4:20 PM EDTOriginal source ↗VTRS: third_quarter 2026 lobbying report
S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; Drug Shortages; Medicaid Generics Penalty.
Public: Oct 7, 2026, 6:43 AM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.